Abstract
Purpose
Preparation of Nanographene oxide (NGO) - Gelatin hybrids for efficient treatment of Neuroblastoma.
Methods
Nanohybrids were prepared via non-covalent interactions. Spectroscopic tools have been used to discriminate the chemical states of NGO prior and after gelatin coating, with UV visible spectroscopy revealing the maximum binding capacity of gelatin to NGO. Raman and X-ray photoelectron spectroscopy (XPS) demonstrated NGO and Gelatin_NGO nanohybrids through a new chemical environments produced after noncovalent interaction. Microscopic analyses, atomic force microscopy (AFM) and scanning electron microscopy (SEM) are used to estimate the thickness of samples and the lateral width in the nanoscale, respectively.
Results
The cell viability assay validated Gelatin_NGO nanohybrids as a useful nanocarrier for Carboplatin (CP) release and delivery, without obvious signs of toxicity. The nano-sized NGO (200 nm and 300 nm) did not enable CP to kill the cancer cells efficiently, whilst the CP loaded Gel_NGO 100 nm resulted in a synergistic activity through increasing the local concentration of CP inside the cancer cells.
Conclusions
The nanohybrids provoked high stability and dispersibility in physiological media, as well as enhanced the anticancer activity of the chemotherapy agent Carboplatin (CP) in human neuroblastoma cells.
Similar content being viewed by others
Abbreviations
- AFM:
-
Atomic force microscopy
- CP:
-
Carboplatin
- CP@Gel:
-
Gelatin loaded with carboplatin
- CP@Gel_NGO:
-
Gelatin coated Nanographene oxide loaded with Carboplatin
- CP@NGO:
-
Nanographene oxide loaded with Carboplatin
- CPT:
-
Camptothecin
- DMEM:
-
Dulbecco’s modified eagle medium
- DOX:
-
Doxorubicin
- EDAX:
-
Energy dispersive X-ray analysis
- FBS:
-
Fetal bovine serum
- FWHM:
-
Full width at half maximum
- Gel:
-
Gelatin
- Gel_NGO:
-
Gelatin coated nanographene oxide
- GNS:
-
Graphene nanosheets
- GO:
-
Graphene oxide
- hMSCs:
-
Human mesenchymal stem cells
- IMR-32:
-
Human neuroblastoma cells
- LE:
-
Loading efficiency
- NGO:
-
Nanographene oxide
- PAMAM:
-
Polyamidoamide
- PBS:
-
Phosphate buffered saline
- PEG:
-
Polyethylene glycol
- Rho:
-
Rhodamine B
- Rho@Gel_NGO:
-
Gelatin coated nanographene oxide loaded with rhodamine B
- RT:
-
Room temperature
- SD:
-
Standard deviation
- SEM:
-
Scanning electron microscope
- SN-38:
-
7-ethyl-10-hydroxycamptothecin
- XPS:
-
X-ray photoelectron spectroscopy
References
Novoselov KS, Jiang D, Schedin F, Booth TJ, Khotkevich VV, Morozov SV, et al. Two-dimensional atomic crystals. Proc Natl Acad Sci U S A. 2005;102:10451–3.
Novoselov KS, Geim AK, Morozov SV, Jiang D, Zhang Y, Dubonos SV, et al. Electric field effect in atomically thin carbon films. Science. 2004;306:666–9.
Makharza S, Cirillo G, Bachmatiuk A, Ibrahim I, Ioannides N, Trzebicka B, et al. Graphene oxide-based drug delivery vehicles: functionalization, characterization, and cytotoxicity evaluation. J Nanoparticle Res. 2013;15:2099–124.
Georgakilas V, Otyepka M, Bourlinos AB, Chandra V, Kim N, Kemp KC, et al. Functionalization of graphene: covalent and non-covalent approaches, derivatives and applications. Chem Rev. 2012;112:6156–214.
Wang Y, Li Z, Wang J, Li J, Lin Y. Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol. 2011;29:205–12.
Zhang W, Guo Z, Huang D, Liu Z, Guo X, Zhong H. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 2011;32:8555–61.
Liu Z, Robinson JT, Sun X, Dai H. PEGylated nano-graphene oxide for delivery of water insoluble cancer drugs. J Am Chem Soc. 2008;130:10876–7.
Shen H, Liu M, He H, Zhang L, Huang J, Chong Y, et al. PEGylated graphene oxide-mediated protein delivery for cell function regulation. ACS Appl Mater Interfaces. 2012;4:6317–23.
Tan X, Feng L, Zhang J, Yang K, Zhang S, Liu Z, et al. Functionalization of graphene oxide generates a unique interface for selective serum protein interactions. ACS Appl Mater Interfaces. 2013;5:1370–7.
Yang K, Zhang S, Zhang G, Sun X, Lee S-T, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010;10:3318–23.
Lee DY, Khatun Z, Lee J-H, Lee Y-K, In I. Blood compatible graphene/heparin conjugate through noncovalent chemistry. Biomacromolecules. 2011;12:336–41.
Zhang S, Yang K, Feng L, Liu Z. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon. 2011;49:4040–9.
Tang L, Wang Y, Liu Y, Li J. DNA-directed self-assembly of graphene oxide with applications to ultrasensitive oligonucleotide assay. 2011;3817–22.
Bao H, Pan Y, Ping Y, Sahoo NG, Wu T, Li L, et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small. 2011;7:1569–78.
An J, Gou Y, Yang C, Hu F, Wang C. Synthesis of a biocompatible gelatin functionalized graphene nanosheets and its application for drug delivery. Mater Sci Eng C. 2013;33:2827–37.
Makharza S, Cirillo G, Bachmatiuk A, Vittorio O, Mendes RG, Oswald S, et al. Size-dependent nanographene oxide as a platform for efficient carboplatin release. J Mater Chem B. 2013;1:6107–14.
Cirillo G, Vittorio O, Hampel S, Spizzirri UG, Picci N, Iemma F. Incorporation of carbon nanotubes into a gelatin-catechin conjugate: innovative approach for the preparation of anticancer materials. Int J Pharm. 2013;446:176–82.
Zheng W, Zheng YF. Gelatin-functionalized carbon nanotubes for the bioelectrochemistry of hemoglobin. Electrochem Commun. 2007;9:1619–23.
Liu K, Zhang JJ, Cheng FF, Zheng TT, Wang C, Zhu JJ. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J Mater Chem. 2011;21:12034–40.
Hummers WS, Offeman RE. Preparation of graphitic oxide. J Am Chem Soc. 1958;80:1339–9.
Sun X, Luo D, Liu J, Evans DG. Monodisperse chemically modified graphene obtained by density gradient ultracentrifugal rate separation. ACS Nano. 2010;4:3381–9.
Horcas I, Fernández R, Gómez-Rodríguez JM, Colchero J, Gómez-Herrero J, Baro AM. WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum. 2007;78:013705–8.
Schniepp HC, Li JL, McAllister MJ, Sai H, Herrera-Alonso M, Adamson DH, et al. Functionalized single graphene sheets derived from splitting graphite oxide. J Phys Chem B. 2006;110:8535–9.
Kudin KN, Ozbas B, Schniepp HC, Prud’homme RK, Aksay IA, Car R. Raman spectra of graphite oxide and functionalized graphene sheets. Nano Lett. 2008;8:36–41.
Pimenta MA, Dresselhaus G, Dresselhaus MS, Cançado LG, Jorio A, Saito R. Studying disorder in graphite-based systems by Raman spectroscopy. Phys Chem Chem Phys. 2007;9:1276–91.
Haubner K, Murawski J, Olk P. The route to functional graphene oxide. ChemPhysChem. 2010;11:2131–9.
Yang H, Shan C, Li F, Han D, Zhang Q, Niu L. Covalent functionalization of polydisperse chemically-converted graphene sheets with amine-terminated ionic liquid. Chem. Commun. 2009;3880–2.
Biesinger MC, Payne BP, Grosvenor AP, Lau LWM, Gerson AR, Smart RSC. Resolving surface chemical states in XPS analysis of first row transition metals, oxides and hydroxides: Cr, Mn, Fe, Co and Ni. Appl Surf Sci. 2011;257:2717–30.
Yi H-B, Lee HM, Kim KS. Interaction of benzene with transition metal cations: theoretical study of structures, energies, and IR spectra. J Chem Theory Comput. 2009;5:1709–17.
Spizzirri UG, Hampel S, Cirillo G, Nicoletta FP, Hassan A, Vittorio O, et al. Spherical gelatin/CNTs hybrid microgels as electro-responsive drug delivery systems. Int J Pharm. 2013;448:115–22.
Yue H, Wei W, Yue Z, Wang B, Luo N, Gao Y, et al. The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials. 2012;33:4013–21.
Vittorio O, Cirillo G, Iemma F, Di Turi G, Jacchetti E, Curcio M, et al. Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma. Pharm Res. 2012;29:2601–14.
Akhavan O, Ghaderi E, Akhavan A. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials. 2012;33:8017–25.
Chng ELK, Sofer Z, Pumera M. Cytotoxicity profile of highly hydrogenated graphene. Chem Eur J. 2014;20:6366–73.
Ku SH, Lee M, Park CB. Carbon-based nanomaterials for tissue engineering. Adv Healthcare Mat. 2013;2:244–60.
Pryzhkova MV. Concise review: carbon nanotechnology: perspectives in stem cell research. Stem Cells Trans Med. 2013;2:376–83.
Musumeci T, Pellitteri R, Spatuzza M, Puglisi G. Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake. J Pharm Sci. 2014;103:628–35.
Acknowledgments and Disclosures
S.M. thanks the DAAD and Al-Quds University. G.C. thanks the financial support of Regional Operative Program (ROP) Calabria ESF 2007/2013IV Axis Human Capital Operative Objective M2 Action D.5. NHMRC Established Career Fellowship Award (M.K.). M.M. acknowledges financial support from the Excellence Cluster for Advancing Electronics Dresden (contract EXC1056). We thank Steffi Kaschube, Marco Rosenkranz, David Kunhard, and Alexander Schubert for lab assistance. O.V. thanks the Cancer Institute New South Wales Fellowship.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 648 kb)
Rights and permissions
About this article
Cite this article
Makharza, S., Vittorio, O., Cirillo, G. et al. Graphene Oxide - Gelatin Nanohybrids as Functional Tools for Enhanced Carboplatin Activity in Neuroblastoma Cells. Pharm Res 32, 2132–2143 (2015). https://doi.org/10.1007/s11095-014-1604-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-014-1604-z